Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Eli Lilly and (NYSE:LLY) with a Overweight ...

Eli Lilly and Co. (LLY) emerged as a beacon of optimism last week in a market filled with uncertainty and volatility. Shares soared over 14% ...

With a market cap of $775.6 billion, Eli Lilly and Company (LLY) is a global biopharmaceutical leader with leading products ...

Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early ...

Sun Pharma is projected to lead in PAT growth at 28% YoY, while Cipla might see a 5% YoY decline, according to Centrum ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

Kerryman Aidan Healy moved from Dublin with his husband, a Westport native, in 2019, and opened Aodha, which sells Irishmade ...

Following the market disruptions triggered by erratic US tariff policy, we speak in this interview with portfolio manager Terence McManus about how the healthcare sector has held up amid this ...

All three companies have had a tough time of it recently in the stock market. But in all three cases, our analysts think that ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Indian benchmark indices, Sensex and Nifty, edged higher on Tuesday as the Reserve Bank of India’s (RBI) liquidity-boosting ...